Skip to main content

Nektar Therapeutics (NASDAQ: NKTR) Investor Securities Class Action Lawsuit 08/19/2019

  • If you purchased shares of Nektar Therapeutics (NASDAQ: NKTR), you may have certain options. Please contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

March 2, 2021 - The case was voluntarily dismissed. January 26, 2021 - The court granted the defendants' motion to dismiss. The plaintiffs were given leave to amend the complaint. April 10, 2020 - A motion to dismiss the amended complaint was filed. January 24, 2020 - An amended complaint was filed. August 19, 2019 - An investor in shares of Nektar Therapeutics (NASDAQ: NKTR) filed a ...



You must register (for free) or login to view the entire case.